Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Faculty of Medicine, Cairo, Shebin El-kom, Egypt
Hospital del Mar, Barcelona, Spain
Faculty of Medicine, Cairo, Shebin El-kom, Egypt
Univeristy Neuropsychiatric Institute, Salt Lake City, Utah, United States
Peking Union Medical College Hospital, Beijing, Beijing, China
The University of Hong Kong, Hong Kong, Hong Kong
Helse Fonna, Haugesund Sykehus, Haugesund, Norway
Kirurgisk Klinikk-Anestesi, Haugesund, Rogaland, Norway
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.